Stephanie Dekovic
Senior Director of Investor Relations, iRhythm
Replay available
iRhythm Holdings, Inc. (NASDAQ: IRTC) Q3 2025 earnings conference call, held 2025-10-30. Replay captured from the company's public earnings webcast.

Senior Director of Investor Relations, iRhythm
President and Chief Executive Officer, iRhythm
Chief Financial Officer, iRhythm
Analyst, Wells Fargo Securities
Analyst, Citigroup
Analyst, Truist Securities
Analyst, Needleman Company
Analyst, Oppenheimer & Co.
Analyst, Beard Research
Analyst, Bank of America
Analyst, William Blair
Analyst, Canaccord Genuity
Analyst, Goldman Sachs
Analyst, Freedom Capital Markets
the conference over to our host, Stephanie Dekovic, the Senior Director of Investor Relations. Please proceed. Thank you all for participating in today's call. Earlier today, iRhythm released financial results for the third quarter ended September 30th, 2025. Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws. pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call, they're not statements of historical fact, should be deemed to be forward-looking statements. These are based upon our current estimates and various assumptions and reflect management's intentions, beliefs, and expectations about future events, strategies, competition, products, operating plans, and performance. These statements involve risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the risk factors section of our most recent annual and quarterly reports on Form 10-K and Form 10-Q, respectively, filed with the Securities and Exchange Commission. Also during the call, we will discuss certain financial measures that have not been prepared in accordance with U.S. GAAP with respect to our non-GAAP and cash-based results, including adjusted EBITDA, adjusted operating expenses, and adjusted net loss. Unless otherwise noted, all references to financial metrics are presented on a non-GAAP basis. The presentation of this additional...